DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
S••••• T••••••••• P••
Pharmaceuticals, Biotechnology & Life Sciencesgroup grade Aon a schedule nowsponsor unattributed
Principal held
at least $25.0M
sum of BDC pieces, a lower bound
Fair value
$25.3M
104c on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
1 equity pieces beside them
Next maturity
Sep 28, 2028
no dated debt inside 24 months
On the tape since
Dec 31, 2025
latest Jun 30, 2026
Events
2
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $25.0M | 104c | SOFR+875 bp | Sep 28, 2028 | 1 |
Equity pieces beside the debt: warrants ($213,000 fair value, 1 BDC)
Lenders
every BDC piece at the latest quarter end
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| R••••• G••••• F•••••• C•••• | term loan first lien Investment Type Senior Secured Interest Rate SOFR+8.75%, 12.25% floor, 6.56% ETP Acquisiti | $20.0M | $20.1M 105c | SOFR+875 bp |
| R••••• G••••• F•••••• C•••• | warrants equity Warrants & Other Contractual Rights Investment Type Warrant Common Stock Initial Acquisiti | n/a | $30,000 48c | |
| R••••• G••••• F•••••• C•••• | warrants equity Warrants & Other Contractual Rights Investment Type Warrant Common Stock Initial Acquisiti | n/a | $117,000 22c | |
| R••••• G••••• F•••••• C•••• | term loan first lien Investment Type Senior Secured Interest Rate SOFR+8.75%, 12.25% floor, 5.00% ETP Acquisiti | $5.0M | $5.0M 103c | SOFR+875 bp |
| R••••• G••••• F•••••• C•••• | warrants equity Warrants & Other Contractual Rights Investment Type Warrant Common Stock Initial Acquisiti | n/a | $66,000 99c |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 1 | $25.0M | $25.1M | 104c | 0 |
| Mar 31, 2026 | 1 | $2.0M | $2.0M | 100c | 0 |
| Dec 31, 2025 | 1 | $4.0M | $3.9M | 99c | 0 |
What changed
- Spread changed (observed)Mar 31, 2026
- New borrower on a BDC scheduleDec 31, 2025
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- S••••• T•••••••••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- Pharmaceuticals, Biotechnology & Life Sciencesreportedas one filer wrote it